Select a Sector or Industry
Earnings Per Share Growth Rankings for Drug Manufacturers - Other Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Earnings Per Share Growth
|
Pro Rating
|
|---|---|---|---|---|
| 1 | TARO | Taro Pharmaceutical Industries | 1173% | Go Pro |
| 2 | UTHR | United Therapeutics Corporation | 396.2% | Go Pro |
| 3 | SCLN | SciClone Pharmaceuticals | 87.50% | Go Pro |
| 4 | RDY | Dr. Reddy's Laboratories | 50.00% | Go Pro |
| 5 | AGN | Allergan | 45.10% | Go Pro |
| 6 | CBST | Cubist Pharmaceuticals | 32.35% | Go Pro |
| 7 | NVO | Novo Nordisk | 14.73% | Go Pro |
| 8 | PTX | Pernix Therapeutics | 0.00% | Go Pro |
| 9 | SCR | Simcere Pharmaceutical Group | -25.00% | Go Pro |
| 10 | CPIX | Cumberland Pharmaceuticals | -33.33% | Go Pro |
| 11 | FRX | Forest Laboratories | -33.94% | Go Pro |
| 12 | TPI | Tianyin Pharmaceutical | -57.14% | Go Pro |
| 13 | MDCO | The Medicines Company | -68.89% | Go Pro |
| 14 | GENT | Gentium | -83.33% | Go Pro |
